hotspot -WSS

hotspot

author：leisure time 2025-09-28 02:32:16 - browse：16634

CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early clinical data presented Monday at the American Society of Clinical Oncology annual meeting. The study, though preliminary and small with only 24 patients, represents a triad of firsts for one of the trial’s sponsors.

“It’s the first CAR therapy working in liver cancer. First validation of targeting GPC3 as a target. It’s the first validation of our armoring strategy. And it’s the first of many of our visions of CAR therapy in general,” Matt Hellmann, a medical oncologist and early development oncology lead at AstraZeneca, said in an interview.

This abstract, presented by cancer researcher Qi Zhang of Zhejiang University School of Medicine, is yet another significant showing by AstraZeneca at this ASCO. The company had two plenary presentations on its blockbuster lung cancer drug Tagrisso and immunotherapy drug Imfinzi — as well as new results on Enhertu, which AstraZeneca developed with Daiichi Sankyo.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Study finds gene variants tied to breast cancer risk in Black women

entertainment

WSS

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Bright Health sells Medicare Advantage business to Molina

Cue Health, Covid

Medical records are filled with copy

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Wildfire smoke exposes gaps in outdoor worker protections

Following judge's order, DOJ releases slightly less

Novavax promises a turnaround & Lilly roils the obesity market

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

hotspot

Investigation reveals sickle cell patients pressured into sterilizations

Condition critical? Britain's beloved but battered National Health Service turns 75

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Adele warns fans about throwing things at performers onstage

Princess Kate attends Wimbledon with Roger Federer: See the photos

knowledge

leisure time

entertainment

knowledge